IP Verse

Symbiosis patent opposition analysis

The comprehensive analysis of Symbiosis opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Symbiosis

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	MERCK SHARP & DOHME	May 26, 2022	SYMBIOSIS
EP3283882	Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists	MERCK SHARP & DOHME	Sep 15, 2021	SYMBIOSIS

Top companies who are the clients of Symbiosis

Company	Total
SYMBIOSIS	2